C1orf106 | Chromosome 1 open reading frame 106 | | | | | | Tissue enhanced |
C1orf109 | Chromosome 1 open reading frame 109 | | | | | | Expressed in all |
C1orf167 | Chromosome 1 open reading frame 167 | | | | | | Group enriched |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
C1orf192 | Chromosome 1 open reading frame 192 | | | | | | Tissue enriched |
C1orf194 | Chromosome 1 open reading frame 194 | | | | | | Group enriched |
C1orf222 | Chromosome 1 open reading frame 222 | | | | | | Tissue enhanced |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C1orf87 | Chromosome 1 open reading frame 87 | | | | | | Group enriched |
C20orf85 | Chromosome 20 open reading frame 85 | | | | | | Tissue enriched |
C22orf42 | Chromosome 22 open reading frame 42 | | | | | | Tissue enriched |
C2orf42 | Chromosome 2 open reading frame 42 | | | | | | Expressed in all |
C2orf50 | Chromosome 2 open reading frame 50 | | | | | | Tissue enriched |
C2orf57 | Chromosome 2 open reading frame 57 | | | | | | Tissue enriched |
C2orf82 | Chromosome 2 open reading frame 82 | Predicted membrane proteins
| | | | | Tissue enhanced |
C3orf20 | Chromosome 3 open reading frame 20 | | | | | | Tissue enriched |
C3orf22 | Chromosome 3 open reading frame 22 | | | | | | Tissue enriched |
C3orf30 | Chromosome 3 open reading frame 30 | | | | | | Tissue enriched |
C4orf29 | Chromosome 4 open reading frame 29 | | | | | | Expressed in all |
C5orf60 | Chromosome 5 open reading frame 60 | Predicted membrane proteins
| | | | | Tissue enriched |
C6orf52 | Chromosome 6 open reading frame 52 | | | | | | Tissue enhanced |
C6orf62 | Chromosome 6 open reading frame 62 | | | | | | Expressed in all |
C7orf61 | Chromosome 7 open reading frame 61 | | | | | | Tissue enriched |
C7orf63 | Chromosome 7 open reading frame 63 | | | | | | Tissue enhanced |
C8orf47 | Chromosome 8 open reading frame 47 | | | | | | Tissue enhanced |
C9orf117 | Chromosome 9 open reading frame 117 | | | | | | Tissue enriched |
C9orf43 | Chromosome 9 open reading frame 43 | | | | | | Tissue enriched |
CABS1 | Calcium-binding protein, spermatid-specific 1 | | | | | | Tissue enriched |
CACNG8 | Calcium channel, voltage-dependent, gamma subunit 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CADM2 | Cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CAPSL | Calcyphosine-like | | | | | | Tissue enriched |
CARD10 | Caspase recruitment domain family, member 10 | Plasma proteins
| | | | | Mixed |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC113 | Coiled-coil domain containing 113 | | | | | | Tissue enhanced |
CCDC146 | Coiled-coil domain containing 146 | | | | | | Expressed in all |
CCDC15 | Coiled-coil domain containing 15 | | | | | | Tissue enhanced |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CCDC173 | Coiled-coil domain containing 173 | | | | | | Tissue enriched |
CCDC178 | Coiled-coil domain containing 178 | | | | | | Tissue enhanced |
CCDC181 | Coiled-coil domain containing 181 | | | | | | Tissue enhanced |
CCDC19 | Coiled-coil domain containing 19 | | | | | | Group enriched |
CCDC37 | Coiled-coil domain containing 37 | | | | | | Group enriched |
CCDC39 | Coiled-coil domain containing 39 | Cytoskeleton related proteins Disease related genes
| | | | | Tissue enhanced |
CCDC40 | Coiled-coil domain containing 40 | Disease related genes
| | | | | Tissue enhanced |
CCDC42B | Coiled-coil domain containing 42B | | | | | | Tissue enriched |
CCDC57 | Coiled-coil domain containing 57 | | | | | | Expressed in all |
CCDC68 | Coiled-coil domain containing 68 | | | | | | Mixed |
CCDC96 | Coiled-coil domain containing 96 | Plasma proteins
| | | | | Group enriched |
CCNG2 | Cyclin G2 | Cancer-related genes
| | | | | Expressed in all |
CCSER2 | Coiled-coil serine-rich protein 2 | | | | | | Expressed in all |